Agios Pharmaceuticals, Inc. (LON:0HB0)
33.74
+0.66 (1.99%)
At close: Jun 27, 2025
Agios Pharmaceuticals Revenue
Agios Pharmaceuticals had revenue of $8.73M USD in the quarter ending March 31, 2025, with 6.56% growth. This brings the company's revenue in the last twelve months to $37.04M, up 25.96% year-over-year. In the year 2024, Agios Pharmaceuticals had annual revenue of $36.50M with 36.07% growth.
Revenue (ttm)
$37.04M
Revenue Growth
+25.96%
P/S Ratio
49.31
Revenue / Employee
$75.89K
Employees
488
Market Cap
1.41B GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Oxford Nanopore Technologies | 183.19M |
Agios Pharmaceuticals News
- 19 days ago - Agios Pharmaceuticals: A More Compelling Valuation - Seeking Alpha
- 21 days ago - Avanzanite Announces Pan-European Partnership with Agios to Launch PYRUKYND® in Rare Blood Disorders - Business Wire
- 4 weeks ago - Agios to Present at Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025 - GlobeNewsWire
- 6 weeks ago - Agios to Highlight Pyruvate Kinase Activation Portfolio with New Data in Rare Blood Disorders at 30th EHA Congress - GlobeNewsWire
- 7 weeks ago - Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025 - GlobeNewsWire
- 2 months ago - Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025 - GlobeNewsWire
- 2 months ago - Agios Pharmaceuticals, Inc. 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Agios pharmaceuticals outlines key catalysts for PYRUKYND pipeline in 2025 - Seeking Alpha